Pacemaker

The 5-year rates of major complications and need for system revision were very low for patients receiving a transcatheter leadless pacemaker implant, according to real-world data published in the European Heart Journal.

Healio has compiled a list of the top headlines in cardiology from February 2024.

Most patients who receive a pacemaker are likely not thinking about its potential usefulness after their death; however, a viable, properly reconditioned device could help meet an overwhelming need outside of the United States.

One of 2023’s most impactful FDA approvals in cardiology was for the world’s first dual-chamber leadless pacing system. In November, the technology was named one of Time magazine’s best inventions of the year.

PHILADELPHIA — A novel adhesive-based wearable cardioverter defibrillator was associated with high rates of patient compliance and low rates of adverse events, researchers reported at the American Heart Association Scientific Sessions.

PHILADELPHIA — Researchers at the University of Washington have developed prototype piezoelectric devices to convert energy from a heartbeat into electricity that could recharge the battery of a leadless pacemaker.

Adaptive pacing at a 60 bpm base rate did not reduce atrial fibrillation risk in patients with sinus node dysfunction but did reduce the incidence of syncope or presyncope vs. a 40 bpm base rate without adaptive pacing, a speaker reported.

Healio | Cardiology Today has compiled a list of the top headlines in cardiology of July 2023.

In patients with severe aortic stenosis and obesity, transcatheter aortic valve replacement was associated with better rates of in-hospital mortality and other outcomes compared with surgery, according to a meta-analysis.

Biotronik announced the FDA approved its portfolio of pacemakers and cardiac resynchronization therapy pacemakers featuring automatic MRI detection designed to streamline MRI workflow.